Encompass Health Corp Quarterly Interest Expense in USD from Q3 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Encompass Health Corp quarterly/annual Interest Expense history and growth rate from Q3 2015 to Q1 2024.
  • Encompass Health Corp Interest Expense for the quarter ending March 31, 2024 was $35.2M, a 3.3% decline year-over-year.
  • Encompass Health Corp Interest Expense for the twelve months ending March 31, 2024 was $142M, a 17.5% decline year-over-year.
  • Encompass Health Corp annual Interest Expense for 2023 was $144M, a 18.3% decline from 2022.
  • Encompass Health Corp annual Interest Expense for 2022 was $176M, a 6.94% increase from 2021.
  • Encompass Health Corp annual Interest Expense for 2021 was $164M, a 10.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $142M $35.2M -$1.2M -3.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $144M $34.9M -$2.6M -6.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $146M $35.9M -$2.3M -6.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $148M $36.3M -$24.1M -39.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $173M $36.4M -$3.2M -8.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $176M $37.5M -$2.3M -5.78% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $178M $38.2M -$1.7M -4.26% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $180M $60.4M +$18.6M +44.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $161M $39.6M -$3.2M -7.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $164M $39.8M -$5.9M -12.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $170M $39.9M -$9.1M -18.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $179M $41.8M -$4M -8.73% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $183M $42.8M -$400K -0.93% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $184M $45.7M +$1.2M +2.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $183M $49M +$8.7M +21.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $174M $45.8M +$8.1M +21.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $166M $43.2M +$6M +16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $160M $44.5M +$7.8M +21.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $152M $40.3M +$3M +8.04% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $149M $37.7M $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $149M $37.2M +$1.6M +4.49% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $147M $36.7M +$800K +2.23% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $147M $37.3M +$500K +1.36% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $146M $37.7M -$2.7M -6.68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $149M $35.6M -$5.7M -13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $154M $35.9M -$5.7M -13.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $160M $36.8M -$5.7M -13.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $166M $40.4M -$3M -6.91% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $169M $41.3M -$3.3M -7.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $172M $41.6M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $42.5M +$6.9M +19.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $43.4M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $44.6M Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q3 2015 $35.6M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.